Cargando…

Comprehensive Evaluation of the m(6)A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is known for its high drug resistance. The tumor-immune crosstalk mediated by the epigenetic regulation of N6-methyladenosine (m(6)A) modification has been demonstrated in recent studies. Therefore, m(6)A modification-mediated immune cell infiltrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Mingke, Liu, Xuefei, Xu, Han, Shen, Sangyu, Wang, Fajiu, Chen, Dajin, Li, Guorong, Wang, Zongping, Zuo, Zhixiang, Zhao, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248360/ https://www.ncbi.nlm.nih.gov/pubmed/35784363 http://dx.doi.org/10.3389/fimmu.2022.818120

Ejemplares similares

Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma
por: Lu, Caibao, et al.
Publicado: (2022)

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma
por: Qin, Chengdong, et al.
Publicado: (2023)

Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
por: Yao, Qinfan, et al.
Publicado: (2023)

Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma
por: Zhou, Peng, et al.
Publicado: (2022)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2022)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis
por: Yue, Youwei, et al.
Publicado: (2023)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs
por: Hao, Chao, et al.
Publicado: (2023)

Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Ding, Guixin, et al.
Publicado: (2023)

Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis
por: Xie, Linli, et al.
Publicado: (2022)

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
por: Lin, Enyu, et al.
Publicado: (2022)

OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
por: Gong, Mancheng, et al.
Publicado: (2022)

Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
por: Zhang, Ganghua, et al.
Publicado: (2022)

Identification of ST3GAL5 as a prognostic biomarker correlating with CD8(+) T cell exhaustion in clear cell renal cell carcinoma
por: Liu, Jiakuan, et al.
Publicado: (2022)

Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes
por: Yang, Lin, et al.
Publicado: (2023)

Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma
por: Yin, Guicao, et al.
Publicado: (2023)

Comprehensive exploration of the expression and prognostic value of AQPs in clear cell renal cell carcinoma
por: Wang, Huanrui, et al.
Publicado: (2022)

A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment
por: Jiang, Zhongji, et al.
Publicado: (2022)

Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
por: Hou, Lin, et al.
Publicado: (2023)

Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2022)

Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration
por: Liu, Bin, et al.
Publicado: (2021)

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments
por: Wang, Tengda, et al.
Publicado: (2022)

Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Ubiquitin Modification Patterns of Clear Cell Renal Cell Carcinoma and the Ubiquitin Score to Aid Immunotherapy and Targeted Therapy
por: Zhou, Peng, et al.
Publicado: (2021)

Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy
por: Chen, Ronghui, et al.
Publicado: (2023)

A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)

Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
por: Zuo, Shuguang, et al.
Publicado: (2020)

Meta-Analysis of the Diagnostic Value of Cell-free DNA for Renal Cancer
por: Xu, Yipeng, et al.
Publicado: (2021)

The use of an oxidative stress scoring system in prognostic prediction for kidney renal clear cell carcinoma
por: Wang, Xianjin, et al.
Publicado: (2021)

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
por: Feng, Huayi, et al.
Publicado: (2022)

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm
por: Chen, Siteng, et al.
Publicado: (2022)

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab
por: Lyu, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9fu7j7ot17939e09qrmb9pjbum